Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-10-06
1994-01-11
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514284, 546 77, 544125, A61K 31435, C07D22102
Patent
active
052781593
ABSTRACT:
Described are new 17.beta.-aryl ester carboxylates of 4-aza-5.alpha.-androstan-3-ones and related compounds and the use of such compounds as 5.alpha.-reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenetic related disorders.
REFERENCES:
patent: 2227876 (1941-01-01), Bolt
patent: 3239417 (1966-03-01), DiTullio et al.
patent: 3264301 (1966-08-01), Doorenboos
patent: 3285918 (1966-11-01), Doorenboos et al.
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4317817 (1982-03-01), Blohm et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4596812 (1986-06-01), Chidsey, III et al.
patent: 4732897 (1988-03-01), Cainelli et al.
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 4859681 (1989-08-01), Rasmusson et al.
patent: 4882319 (1989-11-01), Holt et al.
patent: 4910226 (1990-03-01), Holt et al.
patent: 5049562 (1991-09-01), Rasmusson et al.
patent: 5175155 (1992-12-01), Juniewicz
Stinson, Chem. & Eng. News, Jun. 29, 1992 pp. 7-8.
Helyker, Wall Street Jour. Jun. 7, 1991, pp. A1, A7 (1991).
Endo., vol. 91, No. 2, pp. 427-437 (1972) by Neri, et al., "A Biological Profile of a Non-steroidal Antiandrogen, SCH 13521 . . . ".
Steroids, 14, 269-283 (1969), by Nayfeh, et al., "Metabolism of Progesterone by Rat Testicular Homogenates-III".
J. Pharm. Sci., 62, No. 4, pp. 638-640 (1973) by Doorenbos and Solomons, "Synthesis & Antimicrobial Properties of 17 Beta-Isopentyloxy-4-Aza-5 Alpha-Androstane and the 4-Methyl Derivative".
J. Pharm. Sci., 60, No. 8, pp. 1234-1235 (1971) by Doorenbos and Brown, "4,17 Alpha-Dimethyl-4-Aza-5-Alpha-Androstan-17 beta-ol Acetate & Related Azasteroids".
J. Pharm., 63, No. 4, pp. 620-622 (1974) by Doorenbos and Kim, "Synthesis & Evaluation of Antimicrobial Properties of Amidinoazaandrostanes and Guanidinoazaandrostanes".
J. Med. Chem. (1986) 29 (11): pp. 2298-3015 by Rasmusson, et al., "Aza Steroids: Structure-Activity Relationships".
Prostate (1986) 9 (1): pp. 65-75 by Brooks, et al., "Prostatic Effects Induced in Dogs By . . . 5 alpha-Reductase Inhibitors".
Steroids (1986) 47 (1) pp. 1-19 by Brooks, et al., "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Aza-Steroids in the rat".
Endocr. (1985) 117 (2): pp. 571-579, by Liang, et al., "Species Differences in Prostatic Steroidal 5 Alpha-Reductases of Rat, Dog and Human".
J. Med. Chem. (1984) 27 (12) pp. 1690-1701, by Rasmusson, et al., "Azasteroids as Inhibitors of Rat Prostatic 5 alpha-reductase".
J. Org. Chem. (1981) vol. 46, No. 7, pp. 1442-1446, T. Back, et al., "N-Chloroazasteroids . . . ".
Chem. Abstracts, vol. 95, 109055j, by T. Liang, et al. "Inhibition of 5 Alpha-Receptor Binding . . . by a 4-Methyl-4-Aza-Steroid" (1981).
JNCI, vol. 74, No. 2, pp. 475-481 (Feb. 1985), by N. Kadohama, et al., "Retardation of Prostate Tumor Progession in the Noble Rate by 4-Methyl-4-Aza-Steroidal Inhibitors of 5 Alpha-Reductase".
The Prostate, vol. 10, pp. 189-197 (1987) by G. Andriole, et al., "The Effect of 4MA . . . on the Growth of . . . Human Tumors . . . ".
J. Endocr., vol. 57, pp. 111-121 (1973) by K. D. Bingham, et al., "The Metabolism of Testosterone by Human Male Scalp Skin".
Toxicol. Appl. Pharmacol., vol. 103, pp. 222-227 (1990) by G. L. Kedderis, et al., "Studies With Nitrogen Containing Steroids . . . ".
Bioorganic Chemistry, 17, pp. 372-376 (1986) by B. W. Metacalf, et al., "Patent Inhibiton of Human Steroid . . . by 3-Androstene-3-Carboxylic Acid".
Biochemistry, 1990, vol. 29, pp. 2815-2824, by M. A. Levy, et al., "Inhibition of Rat Liver Steroid 5 Alpha-Reductase . . .".
J. Med. Chem., 1990, vol. 33, pp. 943-950, by D. A. Holt, et al. "Steroidal A Ring Carboxylic Acids . . . ".
J. Steroid Biochem., vol. 34, Nos. 1-6, pp. 571-575 (1989), by M. A. Levy, et al., "Interaction Between Rat Prostatic 5 Alpha-Reductase . . . ".
J. Med. Chem., vol. 33, pp. 937-942 (1990) by D. A. Holt, et al., "Steroidal A Ring Aryl Carboxylic Acids".
TIPS, Dec. 1989, vol. 10, pp. 491-495, by D. W. Metcalf, et al., "Inhibitors of . . . 5 Alpha-Reductase in Benign Prostatic Hyperplasia . . . ".
Steroids, vol. 35, No. 3 (Mar. 1980) pp. 1-7, by L. Murphy, et al., "Effect of Estradiol on a . . . Binding Protein in the Uterus of the Mouse".
Prostate, vol. 9, pp. 311-318 (1986) by N. Stone, et al., "Estrogen Formation in Human Prostatic Tissue . . . ".
Steroids, vol. 47, No. 1, pp. 1-19 (1986) by J. R. Brooks, et al., "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Azasteroids . . . ".
Lancet, No. 1986, No. 8515, pp. 1095-1096, by F. Labrie, et al. "Combination therapy in prostate cancer".
J. Clin. Endocrin. and Metab., vol. 55, No. 1, pp. 18-193 (1987), by R. Rittmaster, et al., "The Effects of . . . a 5 Alpha-Reductase Inhibitor . . . ".
J. Clin. Endocin and Metab., vol. 74, No. 2, pp. 345-350 (1990), by A. Diani, et al., "Hair Growth Effects of Oral Administration of Finasteride . . . ".
J. Clin. Endocrinol. Metab. 67, No. 4, pp. 808-816 (1988), by N. Bruchovsky, et al., "Kinetic Parameters of 5 Alpha-Reductase Activity in Stroma & Epitelium of Normal Hyperplastic & Carcinomatous Human Prostates".
J. Steroid Biochem. 26, (3) pp. 349-353 (1987), by R. Hudson, "Comparison of Nuclear 5 Alpha-Reductase Activities in the Stromal and Epitelial Fractions of Human Prostatic Tissue".
J. Biol. Chem. 251, (19) pp. 5985-5900 (1976), by R. J. Moore, et al., "Steroid 5 Alpha-Reductase in Cultured Human Fibroblasts".
J. Biol. Chem. 264, (27) pp. 16249-16255 (1989), by S. Andersson, et al., "Expression Cloning & Regulation of steroid 5 alpha-Reductase, an Exzyme Essential for Male Sexual Differentiation".
Proc. Nat'l Acad. Science 87, pp. 3640-3644 (1990), by S. Andersson, et al., "Structural & Biochemical Properties of cloned and expressed human and rat steroid 5 alpha-reductases".
Nature 354, pp. 159-161 (Nov. 14, 1991), by S. Andersson, et al., "Deletion of Steroid 5 Alpha-Reductase-2 Gene in Male Pseudohermaphroditism".
Biol. of Reproduction, vol. 46, pp. 168-173 (1992), by J. D. Wilson, "Syndromes of Androgen Resistance".
Eur. J. Cancer 26 (2), p. 188 (1990), by A. A. Geldof, et al., "Enzyme Inhibitors in Hormone Dependent Prostate Cancer Growth".
J. Cancer Res. Clin. Oncol. 118, pp. 50-55 (1992), by A. Geldof, et al., "Consideration of the Use of . . . 4MA . . . in Prostate Cancer Therapy".
The Prostate 18, pp. 215-227 (1991), by J. Brooks, et al., "Effect of Castration, DES, Flutamide, and MK-906 on Growth of the Dunning Rat Prostatic Carcinoma . . . ".
Eur. J. Pharm. 183 (5), p. 1757 (1990), by Masubuchi, et al., "Lack of DHT Inhibition . . . by Treatment of 4MA . . . ".
Bakshi Raman K.
Patel Gool F.
Rasmusson Gary H.
Caruso Charles M.
Daus Donald G.
Merck & Co. , Inc.
North Robert J.
Quagliato Carol S.
LandOfFree
Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carbo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carbo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carbo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631423